Zydus Lifesciences informs about press release
Zydus Lifesciences has informed that it enclosed press release titled ‘Zydus receives tentative approval from USFDA for Empagliflozin and Linagliptin Tablets, 10 mg/5 mg and 25 mg/5 mg.’.
The above information is a part of company’s filings submitted to BSE.
